卫光生物(002880.SZ)2025年度向特定对象发行A股股票申请获得深圳证券交易所受理

Group 1 - The company, Shenzhen Weiguang Biological Products Co., Ltd., has received a notification from the Shenzhen Stock Exchange regarding the acceptance of its application for a specific object issuance of A-shares [1] - The application documents submitted by the company have been verified as complete by the Shenzhen Stock Exchange, which has decided to accept the application [1] - The issuance of A-shares is subject to approval by the Shenzhen Stock Exchange and registration by the China Securities Regulatory Commission, indicating uncertainty regarding the final approval and timeline [1]